Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
23,165,208
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
382,167
-
Shares change
-
+382,167
-
Total reported value, excl. options
-
$2,847,155
-
Value change
-
+$2,847,155
-
Number of buys
-
10
-
Price
-
$7.45
Significant Holders of ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ACTU) as of Q3 2024
10 filings reported holding ACTU - ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q3 2024.
ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ACTU) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 382,167 shares
of 23,165,208 outstanding shares and own 1.6% of the company stock.
Largest 10 shareholders include AWM Investment Company, Inc. (139,511 shares), Long Corridor Asset Management Ltd (125,000 shares), Royal Bank of Canada (35,300 shares), GEODE CAPITAL MANAGEMENT, LLC (27,893 shares), NORTHWESTERN UNIVERSITY (27,778 shares), KG&L Capital Management,LLC (12,000 shares), CITIGROUP INC (10,973 shares), WELLS FARGO & COMPANY/MN (3,392 shares), Tower Research Capital LLC (TRC) (297 shares), and BANK OF AMERICA CORP /DE/ (23 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.